Sen. Laura M. Murphy
Filed: 3/1/2023
 
 

 

 

 
10300SB1412sam001LRB103 26068 KTG 57981 a



1
AMENDMENT TO SENATE BILL 1412




2    AMENDMENT NO. ______. Amend Senate Bill 1412 on page 1, by 
3replacing lines 7 through 9 with the following:


 
4    "(20 ILCS 2205/2205-40 new)
5    Sec. 2205-40. Generic prescription drug contracting.
6    (a) As used in this Section: 
7    "Eligible prescription drug" means a prescription drug 
8approved under 21 U.S.C. Sec. 355(c) that is not under patent. 
9    "Generic drug" means a drug that is approved in accordance 
10with an application referencing an eligible prescription drug 
11that is submitted under subsection (j) of Section 505 of the 
12federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355(j)). 
13    (b) The Department of Healthcare and Family Services shall 
14implement"; and
 
15on page 3, by replacing line 5 with the following:
16    "(g) As used in this Section: 
 
 
10300SB1412sam001- 2 -LRB103 26068 KTG 57981 a

1    "Eligible prescription drug" means a prescription drug 
2approved under 21 U.S.C. Sec. 355(c) that is not under patent. 
3    "Generic drug" means a drug that is approved in accordance 
4with an application referencing an eligible prescription drug 
5that is submitted under subsection (j) of Section 505 of the 
6federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355(j)). 
7    (h) This Section is repealed on January 1, 2025.".